The future of anti-CD20 monoclonal antibodies: are we making progress?

Abstract:

:The anti-CD20 monoclonal antibody (mAb) rituximab has revolutionized the treatment of B-cell malignancies. This unprecedented success has not only substantially changed the mindset of the clinical community about the ability of mAb to improve outcomes but has catalyzed the interest in the pharmaceutical industry to develop the next generation of anti-CD20 mAbs. Since the introduction of rituximab 15 years ago, we have learned much about the potential mechanisms underlying the therapeutic efficacy of anti-CD20 mAbs. In parallel, many novel anti-CD20 mAbs have entered the clinic, each designed with modifications to structure aimed at further improving efficacy. On review of the newer generation of anti-CD20 mAbs entering clinical trials, it appears that the link between the novel mechanistic insights and the development of these next-generation anti-CD20 mAbs is unclear. As we move into an era of personalized medicine, it will become increasingly important for us to develop closer links between the emerging mechanistic insights and the clinical development, to further enhance the potency of anti-CD20 mAbs beyond that achieved with rituximab.

journal_name

Blood

journal_title

Blood

authors

Alduaij W,Illidge TM

doi

10.1182/blood-2010-07-298356

subject

Has Abstract

pub_date

2011-03-17 00:00:00

pages

2993-3001

issue

11

eissn

0006-4971

issn

1528-0020

pii

blood-2010-07-298356

journal_volume

117

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells.

    abstract::Internal tandem duplication of the Fms-like tyrosine kinase-3 receptor (FLT3) internal tandem duplication (ITD) is found in 30% of acute myeloid leukemia (AML) and is associated with a poor outcome. In addition to tyrosine kinase inhibitors, therapeutic strategies that modulate the expression of FLT3-ITD are also prom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-05-646497

    authors: Larrue C,Saland E,Boutzen H,Vergez F,David M,Joffre C,Hospital MA,Tamburini J,Delabesse E,Manenti S,Sarry JE,Récher C

    更新日期:2016-02-18 00:00:00

  • Preaggregation reactions of platelets.

    abstract::Whether platelet volume increases during the morphological changes preceding aggregation has been investigated. Previous research is controversial; resistive-counting techniques reveal an increase, centrifugal methods do not. Platelets were sized with a computerized, resistive-particle counter before and after incubat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gear AR

    更新日期:1981-09-01 00:00:00

  • Scianna antigens including Rd are expressed by ERMAP.

    abstract::The Scianna blood group encompasses the high-frequency antigens Sc1 and Sc3 and the low-frequency antigen Sc2. Another low-frequency antigen Rd (Radin) was suggested to belong to the Scianna blood group. The molecular basis of the Scianna blood group was unknown. The erythrocyte membrane-associated protein (ERMAP) sha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-07-2064

    authors: Wagner FF,Poole J,Flegel WA

    更新日期:2003-01-15 00:00:00

  • PIP2-dependent regulation of Munc13-4 endocytic recycling: impact on the cytolytic secretory pathway.

    abstract::Cytotoxic lymphocytes clear infected and transformed cells by releasing the content of lytic granules at cytolytic synapses, and the ability of cytolytic effectors to kill in an iterative manner has been documented previously. Although bidirectional trafficking of cytolytic machinery components along the endosomal pat...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-324160

    authors: Capuano C,Paolini R,Molfetta R,Frati L,Santoni A,Galandrini R

    更新日期:2012-03-08 00:00:00

  • Parallel tubular arrays in severe combined immunodeficiency disease: an ultrastructural study of peripheral blood lymphocytes.

    abstract::The ultrastructure of the lymphocytes from three children with severe combined immunodeficiency disease (SCID) is described. Parallel tubular arrays (PTA) were found in a large percentage of circulating lymphocytes (53%, 41%, and 13%) in three SCID patients when compared to age-matched controls. The size of these incl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Payne CM,Jones JF,Sieber OF Jr,Fulginiti VA

    更新日期:1977-07-01 00:00:00

  • Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.

    abstract::Chimeric antigen receptor (CAR) T cells have emerged as a novel form of treatment of patients with B-cell malignancies. In particular, anti-CD19 CAR T-cell therapy has effected impressive clinical responses in B-cell acute lymphoblastic leukemia and diffuse large B-cell lymphoma. However, not all patients respond, and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-04-842708

    authors: Scarfò I,Ormhøj M,Frigault MJ,Castano AP,Lorrey S,Bouffard AA,van Scoyk A,Rodig SJ,Shay AJ,Aster JC,Preffer FI,Weinstock DM,Maus MV

    更新日期:2018-10-04 00:00:00

  • Restoration of phagocyte function by interferon-gamma in X-linked chronic granulomatous disease occurs at the level of a progenitor cell.

    abstract::Phagocytes from X-linked chronic granulomatous disease (X-CGD) patients are deficient in their ability to generate superoxide because of a defective gene that encodes a heavy chain of cytochrome b, a critical component in the superoxide-generating pathway. Previously we have shown that a single in vivo treatment of se...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ezekowitz RA,Sieff CA,Dinauer MC,Nathan DG,Orkin SH,Newburger PE

    更新日期:1990-12-15 00:00:00

  • Interleukin-21 inhibits dendritic cell activation and maturation.

    abstract::Interleukin 21 (IL-21) is a newly described cytokine with homology to IL-4 and IL-15. They belong to a cytokine family that uses the common gamma chain for signaling but also have their private high-affinity receptors. Since it is well known that IL-4 modulates differentiation and activation of dendritic cells (DCs), ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-03-0669

    authors: Brandt K,Bulfone-Paus S,Foster DC,Rückert R

    更新日期:2003-12-01 00:00:00

  • Defective polymorphonuclear leukocyte metabolism and function in canine cyclic neutropenia.

    abstract::Humans and grey collie dogs with cyclic neutropenia are known to suffer from an increased rate of bacterial infection. Because of the previously described microanatomic abnormalities of lysosome formation found in the polymorphonuclear leukocytes (PMNs) of dogs with canine cyclic neutropenia, studies of these cells we...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chusid MJ,Bujak JS,Dale DC

    更新日期:1975-12-01 00:00:00

  • MicroRNA-150 inhibits tumor invasion and metastasis by targeting the chemokine receptor CCR6, in advanced cutaneous T-cell lymphoma.

    abstract::In this study, we show that microRNA-150 (miR-150) is significantly downregulated in advanced cutaneous T-cell lymphoma (CTCL), and that this downregulation is strongly associated with tumor invasion/metastasis. Inoculation of CTCL cell lines into nonobese diabetic/Shi-scid interleukin 2γ (IL-2γ) null mice led to CTCL...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-09-527739

    authors: Ito M,Teshima K,Ikeda S,Kitadate A,Watanabe A,Nara M,Yamashita J,Ohshima K,Sawada K,Tagawa H

    更新日期:2014-03-06 00:00:00

  • Human CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand target both tumor cells and tumor vasculature.

    abstract::Adenovirus-transduced CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (CD34-TRAIL+ cells) exert potent antitumor activity. To further investigate the mechanism(s) of action of CD34-TRAIL+ cells, we analyzed their homing properties as well as antitumor and antivascular effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-08-239632

    authors: Lavazza C,Carlo-Stella C,Giacomini A,Cleris L,Righi M,Sia D,Di Nicola M,Magni M,Longoni P,Milanesi M,Francolini M,Gloghini A,Carbone A,Formelli F,Gianni AM

    更新日期:2010-03-18 00:00:00

  • Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition.

    abstract::C-abl oncogene 1, nonreceptor tyrosine kinase (ABL1) kinase inhibitors such as imatinib mesylate (imatinib) are effective in managing chronic myeloid leukemia (CML) but incapable of eliminating leukemia stem cells (LSCs), suggesting that kinase-independent pathways support LSC survival. Given that the bone marrow (BM)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-07-511907

    authors: Ng KP,Manjeri A,Lee KL,Huang W,Tan SY,Chuah CT,Poellinger L,Ong ST

    更新日期:2014-05-22 00:00:00

  • Antibody response to intravenous immunization following splenic tissue autotransplantation in Sprague-Dawley rats.

    abstract::The response to intravenous challenge with sheep erythrocytes was determined in Sprague-Dawley rats following autotransplantation of splenic tissue into the subcutaneous tissue, peritoneal cavity, or a surgically created omental pouch. There was a marked rise in heterophil antibody titer following intravenous challeng...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schwartz AD,Dadash-Zadeh M,Goldstein R,Luck S,Conway JJ

    更新日期:1977-05-01 00:00:00

  • Proangiogenic stimulation of bone marrow endothelium engages mTOR and is inhibited by simultaneous blockade of mTOR and NF-kappaB.

    abstract::Most bone marrow (BM) malignancies develop in association with an angiogenic phenotype and increased numbers of endothelial cells. The molecular mechanisms involved in the modulation and recruitment of BM endothelium are largely unknown and may provide novel therapeutic targets for neoplastic diseases. We observed tha...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-06-2208

    authors: Costa LF,Balcells M,Edelman ER,Nadler LM,Cardoso AA

    更新日期:2006-01-01 00:00:00

  • Depletion of the C3 component of complement enhances the ability of rituximab-coated target cells to activate human NK cells and improves the efficacy of monoclonal antibody therapy in an in vivo model.

    abstract::Growing evidence indicates antibody-dependent cellular cytotoxicity (ADCC) contributes to the clinical response to monoclonal antibody (mAb) therapy of lymphoma. Recent in vitro analysis suggests C3b can inhibit mAb-induced natural killer (NK)-cell activation and ADCC. Further studies were conducted to assess the effe...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-200469

    authors: Wang SY,Veeramani S,Racila E,Cagley J,Fritzinger DC,Vogel CW,St John W,Weiner GJ

    更新日期:2009-12-17 00:00:00

  • Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism.

    abstract::Interleukin-8 (IL-8) is a neutrophil chemotactic and activating cytokine that is produced in response to several stimuli. Because monocytic cells are important producers of IL-8, we investigated whether interferon-gamma (IFN-gamma), a potent inducer of activation and differentiation of mononuclear phagocytes, affected...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bosco MC,Gusella GL,Espinoza-Delgado I,Longo DL,Varesio L

    更新日期:1994-01-15 00:00:00

  • Elevated serum levels of interleukin-5 in patients with the syndrome of episodic angioedema and eosinophilia.

    abstract::The syndrome of episodic angioedema and eosinophilia is characterized by cyclic edema, marked peripheral blood eosinophilia, and eosinophil degranulation in the dermis. Using a sensitive immunoenzymetric method, we measured serum interleukin (IL)-5 levels in four patients with this syndrome. We also determined the per...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Butterfield JH,Leiferman KM,Abrams J,Silver JE,Bower J,Gonchoroff N,Gleich GJ

    更新日期:1992-02-01 00:00:00

  • SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.

    abstract::Chemokine stromal derived factor 1 (SDF-1) is involved in trafficking of hematopoietic stem cells (HSCs) from the bone marrow (BM) to peripheral blood (PB) and has been found to enhance postischemia angiogenesis. This study was aimed at investigating whether SDF-1 plays a role in differentiation of BM-derived c-kit(+)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-12-4423

    authors: De Falco E,Porcelli D,Torella AR,Straino S,Iachininoto MG,Orlandi A,Truffa S,Biglioli P,Napolitano M,Capogrossi MC,Pesce M

    更新日期:2004-12-01 00:00:00

  • Familial pseudohyperkalemia maps to the same locus as dehydrated hereditary stomatocytosis (hereditary xerocytosis).

    abstract::Familial pseudohyperkalemia is a "leaky red blood cell" condition in which the cells show a temperature-dependent loss of potassium (K) from red blood cells when stored at room temperature, manifesting as apparent hyperkalemia. The red blood cells show a reduced lifespan in vivo but there is no frank hemolysis. Studie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Iolascon A,Stewart GW,Ajetunmobi JF,Perrotta S,Delaunay J,Carella M,Zelante L,Gasparini P

    更新日期:1999-05-01 00:00:00

  • Acute graft-versus-host disease: a bench-to-bedside update.

    abstract::Over the past 5 years, many novel approaches to early diagnosis, prevention, and treatment of acute graft-versus-host disease (aGVHD) have been translated from the bench to the bedside. In this review, we highlight recent discoveries in the context of current aGVHD care. The most significant innovations that have alre...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2014-01-514786

    authors: Holtan SG,Pasquini M,Weisdorf DJ

    更新日期:2014-07-17 00:00:00

  • Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.

    abstract::The inherited skeletal dysplasia osteogenesis imperfecta (OI) results in multiple fractures and is currently treated empirically. We transplanted human first-trimester fetal blood mesenchymal stem cells (MSCs) into homozygous oim mice in utero. This resulted in a two-thirds reduction in long bone fractures (P < .01), ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-08-105809

    authors: Guillot PV,Abass O,Bassett JH,Shefelbine SJ,Bou-Gharios G,Chan J,Kurata H,Williams GR,Polak J,Fisk NM

    更新日期:2008-02-01 00:00:00

  • Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

    abstract::To assess the influence of graft-versus-host disease (GVHD) on recurrent leukemia and survival after allogeneic marrow transplantation, we studied 1,202 patients with acute nonlymphocytic leukemia (ANL), acute lymphocytic leukemia (ALL), and chronic myelogenous leukemia (CML) given unmodified marrow grafts from HLA-id...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Sullivan KM,Weiden PL,Storb R,Witherspoon RP,Fefer A,Fisher L,Buckner CD,Anasetti C,Appelbaum FR,Badger C

    更新日期:1989-05-01 00:00:00

  • Tissue distribution of target antigen has a decisive influence on the outcome of adoptive cancer immunotherapy.

    abstract::Adoptive transfer of allogeneic T cells has unmatched efficacy to eradicate leukemic cells. We therefore sought to evaluate in kinetic terms interactions between T cells and allogeneic leukemic cells. T cells primed against the model B6(dom1) minor histocompatibility antigen were adoptively transferred in irradiated B...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-04-1032

    authors: Meunier MC,Roy-Proulx G,Labrecque N,Perreault C

    更新日期:2003-01-15 00:00:00

  • Quantification of the breakpoint cluster region rearrangement for clinical monitoring in Philadelphia chromosome-positive chronic myeloid leukemia.

    abstract::The purpose of this report was to evaluate scintigraphy analysis of Southern blot hybridization as a method to quantify the breakpoint cluster region (BCR) rearrangement of Philadelphia chromosome (Ph)+ chronic myelogenous leukemia (CML). Cytogenetic and molecular studies performed simultaneously on 474 bone marrow an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Verschraegen CF,Talpaz M,Hirsch-Ginsberg CF,Pherwani R,Rios MB,Stass SA,Kantarjian HM

    更新日期:1995-05-15 00:00:00

  • von Willebrand factor storage and multimerization: 2 independent intracellular processes.

    abstract::The von Willebrand factor propeptide, vW AgII, has been shown to be required for the formation of vWF multimers and sorting of vWF to storage granules; whether these 2 processes are independent events has been unclear. Chimeric constructs of human and canine vWF were developed to further define these processes and to ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Haberichter SL,Fahs SA,Montgomery RR

    更新日期:2000-09-01 00:00:00

  • Global gene expression analysis of human erythroid progenitors.

    abstract::Understanding the pattern of gene expression during erythropoiesis is crucial for a synthesis of erythroid developmental biology. Here, we isolated 4 distinct populations at successive erythropoietin-dependent stages of erythropoiesis, including the terminal, pyknotic stage. The transcriptome was determined using Affy...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-290825

    authors: Merryweather-Clarke AT,Atzberger A,Soneji S,Gray N,Clark K,Waugh C,McGowan SJ,Taylor S,Nandi AK,Wood WG,Roberts DJ,Higgs DR,Buckle VJ,Robson KJ

    更新日期:2011-03-31 00:00:00

  • FCR achieves long-term durable remissions in patients with IGHV-mutated CLL.

    abstract::In chronic lymphocytic leukemia (CLL) patients with mutated IGHV, 3 recent studies have demonstrated prolonged progression-free survival (PFS) after treatment with fludarabine-cyclophosphamide-rituximab (FCR) chemoimmunotherapy. We performed a systematic review to assess the benefit of FCR for patients with CLL and id...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2017-07-731588

    authors: Chai-Adisaksopha C,Brown JR

    更新日期:2017-11-23 00:00:00

  • A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS.

    abstract::This study investigated the immunogenicity of Wilms tumor gene product 1 (WT1)-peptide vaccination in WT1-expressing acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) patients without curative treatment option. Vaccination consisted of granulocyte-macrophage colony-stimulating factor subcutaneously days ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-02-202598

    authors: Keilholz U,Letsch A,Busse A,Asemissen AM,Bauer S,Blau IW,Hofmann WK,Uharek L,Thiel E,Scheibenbogen C

    更新日期:2009-06-25 00:00:00

  • Identification of base substitutions in the promoter regions of the A gamma- and G gamma-globin genes in A gamma- (or G gamma-) beta+-HPFH heterozygotes using the DNA-amplification-synthetic oligonucleotide procedure.

    abstract::DNA amplification combined with hybridization with 32P-labeled synthetic oligonucleotide probes has been used to identify base substitutions in the 5' promoter region of the A gamma globin gene in members of eleven families from China, Sardinia, Canada, and the United States who had a heterozygosity for the A gamma-be...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Yang KG,Stoming TA,Fei YJ,Liang S,Wong SC,Masala B,Huang RB,Wei ZP,Huisman TH

    更新日期:1988-05-01 00:00:00

  • Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells.

    abstract::Because interleukin-10 (IL-10) is a potent differentiation factor of human B cells into mature plasma cells, we investigated its effect on human malignant plasma cells. IL-10 did not induce any differentiation and increase in Ig synthesis in four human IL-6-dependent malignant plasma cell lines. However, it stimulated...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lu ZY,Zhang XG,Rodriguez C,Wijdenes J,Gu ZJ,Morel-Fournier B,Harousseau JL,Bataille R,Rossi JF,Klein B

    更新日期:1995-05-01 00:00:00